Nasdaq Delisting Notice Hits Shuttle Pharmaceuticals Over Late 10-Q
SHPH sits 37% above its 52-week low of $2.576.
Summary
Shuttle Pharmaceuticals received a Nasdaq delisting notice for failing to file its Q2 2026 Form 10-Q on time. The company has 60 days to submit a compliance plan and could face delisting if it fails to regain compliance.
Key Events · Legal and Risk Events · SHPH
-
Nasdaq Noncompliance Notice Received
On August 28, 2026, Nasdaq notified Shuttle Pharmaceuticals that it no longer complies with Listing Rule 5250(c)(1) due to the late filing of its Q2 2026 Form 10-Q.
-
Compliance Plan Deadline
The company must submit a plan to regain compliance by October 27, 2026. If Nasdaq accepts the plan, an extension of up to 180 days (until February 22, 2027) may be granted.
-
Delisting Risk
If the company fails to timely regain compliance, its common stock will be subject to delisting from Nasdaq. No immediate effect on trading, but a noncompliance indicator will be broadcast starting approximately September 4, 2026.
-
Going Concern and Control Weaknesses
This notice compounds existing risks: the company previously disclosed a going concern warning and material weaknesses in internal controls in its last 10-Q.
Analysis · SHPH · Life Sciences
A Nasdaq noncompliance notice landed on Shuttle Pharmaceuticals on August 28, 2026, triggered by the late filing of its Q2 2026 Form 10-Q. The company now has until October 27, 2026, to submit a compliance plan; if Nasdaq accepts it, the deadline to regain compliance could extend to February 22, 2027. This development adds serious governance and listing risk to a company already wrestling with going-concern pressure and material weaknesses in internal controls. Trading continues for now, but the noncompliance indicator will appear on Nasdaq feeds starting around September 4, 2026, which could weigh on the share price.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SHPH was trading at $3.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $2.58 to $55.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.